(Q28251041)

English

Alzheimer disease: progress or profit?

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Alzheimer disease: progress or profit? (English)

0 references

1 reference

Claire Mount

1

0 references

Christian Downton

series ordinal

2

0 references

language of work or name

English

0 references

publication date

July 2006

0 references

published in

Nature Medicine

0 references

volume

12

0 references

page(s)

780-4

0 references

issue

7

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/nm0706-780

0 references

cites work

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

21 January 2018

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

21 January 2018

Current Treatment for Alzheimer Disease and Future Prospects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

21 January 2018

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

21 January 2018

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

21 January 2018

Public funding for Alzheimer disease research in the United States.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM0706-780

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/NM0706-780

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3186570

OpenCitations bibliographic resource ID

3186570

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3186570

(Q28251041)

Alzheimer disease: progress or profit?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)